HVTN704/HPTN 085 Protocol Funding

Project Profile

Title:

HVTN704/HPTN 085 Protocol Funding

Project Period:

10/01/2015 - 11/30/2020

Sponsor:

Fred Hutch/NIH

Principal Investigator:

Michael Keefer, MD

Description:

To evaluate the safety and tolerability of VRC01 broadly neutralizing monoclonal antibodies (bnAb) administered through IV infusion in each of 2 cohorts and to determine if the VRC01 bnAb prevents HIV-1 infection and to estimate the level of efficacy in each of 2 cohorts.